The largest database of trusted experimental protocols

11 protocols using pgex 6p

1

Cloning of Human Eukaryotic Translation Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Complementary DNAs (cDNAs) of the human genes eEF1A, eEF1Bα, eEF1Bγ, eRF1, and eRF3 were obtained by reverse transcription followed by PCR (RT-PCR) using human placenta RNA (Clontech). DNA primers for RT-PCR were chosen based on the reported sequences (GenBankTM accession numbers NM_001402 for eEF1A, X60489 for eEF1Bα, Z11531 for eEF1Bγ, NM_004730 for eRF1, and NM_002094 for eRF3. eEF1A and eEF1Bγ cDNAs were cloned into the EMCV IRES-dependent expression vector pUC-T7-EMCV-His-MCS-ter (20 (link)) to generate pUC-T7-EMCV-His-eEF1A and pUC-T7-EMCV-His-eEF1Bγ, respectively. The eEF1Bα cDNA was cloned into pUC-T7-EMCV-MCS-ter (20 (link)) to construct pUC-T7-EMCV-eEF1Bα. eRF1 and eRF3 cDNAs were cloned into pGEX6P (GE Healthcare) to construct pGEX6P-eRF1 and pGEX6P-eRF3, respectively.
+ Open protocol
+ Expand
2

Recombinant expression and characterization of viral terminase proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synthetic genes encoding PaP3 TerS (Gene ID: 2700603, or orf1), NV1 TerS (Gene ID: 40099729) and LUZ24 TerS (Gene ID: 5896731) were purchased from Genewiz and ligated between BamHI and XhoI restriction sites of the expression vector pGEX-6P (GE Healthcare) (plasmid pGEX-6P-TerS). PaP3 TerL (Gene ID: 2700601, or orf3), also synthesized by Genewiz, was ligated in a pET28a (Novagen) expression vector between BamHI and XhoI (plasmid pET28a_PaP3-TerL). PaP3 ΔC122-TerS was constructed by introducing a stop codon at position E122 of TerS (plasmid pGEX-6P-ΔCTerS). Ala mutants DM-TerS (K17/K19), TM-TerS (K17/K19/K33) and pAla-TerS (K17/K19/K33/R49/R56/K57) were generated using site-directed mutagenesis. All plasmids were sequenced to confirm the fidelity of the DNA sequence. Eurofins Genomics LLC synthesized DNA fragments corresponding to the PaP3 cohesive (cos) site (5′-GCCGGCCCCTTTCCGCGTTA-3′) and complementary fragment, both 5′ Cy3-labeled. The single-stranded complementary cos oligos were annealed to generate double-stranded DNA (dsDNA). A non-specific 5′ Cy3-labeled 24-bp dsDNA (5′-GCACTGCAGTAACTTGTCAGTCAT-3′) generated from single-stranded oligos was used as a negative control.
+ Open protocol
+ Expand
3

Cloning and Purification of TNRC6A cNLS and Importin-α Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
GST-TNRC6A cNLS (residues 1164–1172 of mouse TNRC6A corresponding to residues 1179–1187 of the human protein; numbering according to hTNRC6A isoform 1) and mutants were cloned into pGEX-6P (GE Healthcare) using overlapping oligonucleotides. GST-cNLS fusions were expressed in BL21(DE3) (NEB) cells overnight at 20°C following isopropyl β-D-1-thiogalactopyranoside (IPTG) induction. Mouse Impα1 lacking the IBB domain (mImpα1ΔIBB; residues 70–529; also known as KPNA2) was expressed and purified as previously reported [43 ]. mImpα1ΔIBB mutants were obtained by site-directed mutagenesis and expressed and purified using similar methods as the wild-type protein. Human Impα1ΔIBB (hImpα1ΔIBB) was expressed in BL21(DE3) (NEB) cells in LB media at 25°C for 5 hours after induction with IPTG, and purified using similar techniques. The TNRC6 cNLS: mImpα1ΔIBB complex was isolated as described previously [44 (link)].
+ Open protocol
+ Expand
4

Affinity Purification and Mass Spectrometry of GST-Nax

Check if the same lab product or an alternative is used in the 5 most similar protocols
GST-Nax is a GST fusion protein at the C-terminus (amino acid residues 1489–1681) of mouse Nax (GenBank accession no. NM_009135). pGEX-Nax was prepared by subcloning Nax cDNA from pTRE-mNax [14 (link)] into pGEX-6P (GE Healthcare) to express GST-Nax. The GST-Nax protein was expressed in the E. coli strain BL21, and purified by glutathione affinity chromatography as described previously [15 (link)].
In pull-down experiments, glutathione Sepharose beads (20 μl) were coated with GST fusion proteins (2 μg), and then incubated overnight at 4°C with synaptosomal lysate (200 μg protein) prepared from the adult rat cerebrum, as described previously [17 (link)]. After washing the beads, the bound proteins were solubilized, separated by SDS-PAGE, and stained with Coomassie Brilliant Blue. Specific bands were excised, subjected to in-gel tryptic digestion, and then applied to matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) (Reflex III, Bruker Daltonics). Peptide mass fingerprinting was performed by a Mascot search (http://www.matrixscience.com/) against the NCBI nonredundant protein database.
+ Open protocol
+ Expand
5

Cloning of Protein Expression Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
All plasmids used in this study are listed and described in S1 Table. For cloning, open reading frames were amplified with Phusion DNA polymerase (Thermo Scientific) using primers harbouring relevant restriction sites. Amplicons were thereafter cloned into either the bacterial expression vectors pET28a (Novagen) and pGEX-6p (GE Healthcare) or the yeast expression vector pYES260 (Euroscarf) using indicated restriction enzymes (NEB) and T4 DNA ligase (NEB). Site directed mutagenesis was performed using the QuickChange method (Stratagene). All constructs were verified by DNA sequencing.
+ Open protocol
+ Expand
6

Recombinant Expression of Importins and Influenza Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The genes encoding mouse α1 (Lott et al., 2011 (link)), human importin α3 and α7 (Boivin and Hart, 2011 (link)) were cloned as FL and ΔIBB in vector pET28a (Novagen) and pGEX-6P (GE Healthcare). The IBB-swap mutants (IBB3-importin α1 and IBB1-importin α3) were generated by megaprimer PCR and inserted into a pGEX-6P vector. Influenza A PB2-NLD (res. 678–759) from strain (A/Victoria/75/1995(H3N2)) was inserted into the pGEX-6P vector between BamHI and XhoI sites. MBP-tagged PB2-NLD (res. 678–759) and NP-NLS (res. 155–170) were previously described (Pumroy et al., 2012 (link)). MBP-tagged PB2-biNLS (res. 738–759) was generated by long PCR. Site directed mutagenesis was used to introduce a stop codon after position 487 of importin α3, point mutations R30Q and Q28R in importin α1 and α3, respectively and K718A mutation in PB2. All constructs generated in this study were entirely sequenced to ensure the correctness of the DNA sequence.
+ Open protocol
+ Expand
7

Purification and Pulldown of GST-Fusion Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
For purification of GST-fusion proteins, the GST expression vector (pGex-6P, GE Healthcare) as well as the Flag-expression vector pCMV-Tag2B, both containing the respective insert (murine PID1; wild type and mutated LRP1 ICD; see Figure S2 for structure and mutations of the intracellular LRP1 domain) were transformed into E. coli BL21 (Stratagene). GST fusion proteins were purified via Glutathion Sepharose 4B (GE Healthcare). LRP1-ICDs were released from the column by incubation with PreScission protease (GE Healthcare). Integrity of all recombinant proteins was confirmed by SDS-PAGE. For pulldown analysis either cell or tissue lysates (150 μg) were incubated over night at 4 °C with GST-fusion proteins. Subsequently pulldown and unbound fractions were separated by centrifugation for 3 min at 9000 rpm. Supernatants were harvested (unbound fraction) and sepharose pellets were washed six times using PBS. Finally, pellets were reduced, and PID1-interacting proteins were analysed by Western blotting.
+ Open protocol
+ Expand
8

Recombinant Enzyme Purification and Mutagenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant enzyme was prepared essentially as described previously [12 (link)]. Protein from PIP4K2C (UniGene 6280511) or associated mutants, cloned into the expression vector pGEX6P (GE Healthcare) was expressed and purified from Escherichia coli BL21(DE3). Cultures were induced with 0.4 mM IPTG and probe-sonicated in the presence of protease inhibitors. GST fusion proteins of PI5P4Kγ and PI5P4Kγ+, a mutant with specific activity close to that of the active PI5P4Kα isoform [12 (link)], were harvested by binding to glutathione sepharose beads (GE Healthcare) and cleaved in situ with 50 units of PreScission protease (GE Healthcare) for 4 h at 4°C. Purity was confirmed by SDS/PAGE and protein concentration determined by colorimetric assay (Bio-Rad). Site-directed mutagenesis using the QuikChange technique (Agilent Technologies) was used to generate clones from which mutant forms of PI5P4Kγ and PI5P4Kγ+ were produced (for mutagenesis primers see Supplementary Table S1).
+ Open protocol
+ Expand
9

Cloning and Proteolysis of Gp16 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gene 14, 15, and 16 (Lupo et al., 2016 ) were originally amplified from T7 phage and cloned in the expression vector pET-16b (Sigma-Aldrich) (plasmids pET-16b_gp14 and pET-16b_gp15 and pET-16b_gp16). Limited proteolysis of gp16 was carried out using chymotrypsin (purchased from Sigma) in a molar digestion ratio equal to 200:1 (w/w) gp16:chymotrypsin, as described (Cingolani et al., 2000 (link)). Gp16-C (res. 275-1318) was generated using PCR by amplifying Gp16 region 275-1318, which was then cloned into vector pGEX-6P-1 (GE Life Sciences) between restriction sites BamHI and EcoRI (plasmid pGEX-6P_gp16-C). Gp16-N (res. 1-228) plasmid (pET16b-gp16-N) was generated by introducing stop codon at position G229 in pET-16b_gp16, using site-directed mutagenesis. Gp16-C mutants containing just the VLD were generated by PCR and cloned into vector pGEX-6P-1 (GE Healthcare) between restriction sites BamHI and EcoRI.
+ Open protocol
+ Expand
10

Construction and Characterization of Fluorescent Fusion Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
pET-101-talin was constructed by PCR amplification of the human complementary DNA (cDNA) and direct subcloning of the resulting cDNA in the pET101/D-TOPO plasmid (Invitrogen). To generate the plasmid pET-101-talin-EGFP encoding for talin fused with EGFP at its C-terminus, the cDNA of EGFP was inserted into the AgeI site of pET-101-talin.
pGEX-6P2-mCherry-α-actinin-1, pGEX-6P2-α-actinin-1, pGEX-6P1-EGFP-vinculin-1-851 (Vh) and pGEX-6P1-EGFP-full-length-vinculin were constructed by PCR amplification of the human cDNAs and subcloning of the resulting cDNAs in the EcoRI and NotI sites of pGEX-6P2-mCherry, EcoRI and NotI sites of pGEX-6P2 (GE Healthcare), and SalI and NotI sites of pGEX-6P1-EGFP (for vinculin 1–851 and full-length).
pGEX-6P1-EGFP was a gift of Jan Faix (Hanover). pGEX-6P2-mCherry was constructed by PCR amplification of pmCherry (Clontech) and subcloning of the mCherry cDNA in pGEX-6P2 (GE Healthcare). All the constructs have been verified by sequencing.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!